FindTrial
Sign In

Evaluation on the effectiveness and safety of COVID19 immunization in children with underlying disease

Evaluation on the effectiveness and safety of COVID19 immunization in children with underlying disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007637
Enrollment
330
Registered
2022-08-09
Start date
2022-06-27
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among outpatients 5-15 years old who have underlying diseases such as autoimmune disease, chronic kidney disease, or immunosuppressant taking autoimmune suppressants who visit Seoul National University Children's Hospital, patients who have received a COVID-19 vaccine.

Exclusion criteria

Exclusion criteria: - Children without underlying medical conditions - Children who have never been vaccinated against COVID-19 - When the child or parent does not consent to participate in the study - If the foreign parent is the guardian who has difficulty understanding the explanation and consent form in Korean

Design outcomes

Primary

MeasureTime frame
Adverse Drug Event—

Secondary

MeasureTime frame
COVID-19 infection after vaccination—

Countries

Korea, Republic of

Contacts

Public ContactSeung-Ah Choe

Korea University

seungah9932@gmail.com+82-2-2286-1344

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026